Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP361046.RAhB1XETVT8GvU1_6S_7OCE7n4BTDGFHZ1_Eg6iONvPOQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP361046.RAhB1XETVT8GvU1_6S_7OCE7n4BTDGFHZ1_Eg6iONvPOQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP361046.RAhB1XETVT8GvU1_6S_7OCE7n4BTDGFHZ1_Eg6iONvPOQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP361046.RAhB1XETVT8GvU1_6S_7OCE7n4BTDGFHZ1_Eg6iONvPOQ130_provenance.
- NP361046.RAhB1XETVT8GvU1_6S_7OCE7n4BTDGFHZ1_Eg6iONvPOQ130_assertion description "[This study explored the use of interleukin 2 (IL-2) and interferon gamma (IFN-gamma) gene-modified tumor cells as cellular vaccines for the treatment of bladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP361046.RAhB1XETVT8GvU1_6S_7OCE7n4BTDGFHZ1_Eg6iONvPOQ130_provenance.
- NP361046.RAhB1XETVT8GvU1_6S_7OCE7n4BTDGFHZ1_Eg6iONvPOQ130_assertion evidence source_evidence_literature NP361046.RAhB1XETVT8GvU1_6S_7OCE7n4BTDGFHZ1_Eg6iONvPOQ130_provenance.
- NP361046.RAhB1XETVT8GvU1_6S_7OCE7n4BTDGFHZ1_Eg6iONvPOQ130_assertion SIO_000772 8459207 NP361046.RAhB1XETVT8GvU1_6S_7OCE7n4BTDGFHZ1_Eg6iONvPOQ130_provenance.
- NP361046.RAhB1XETVT8GvU1_6S_7OCE7n4BTDGFHZ1_Eg6iONvPOQ130_assertion wasDerivedFrom befree-20140225 NP361046.RAhB1XETVT8GvU1_6S_7OCE7n4BTDGFHZ1_Eg6iONvPOQ130_provenance.
- NP361046.RAhB1XETVT8GvU1_6S_7OCE7n4BTDGFHZ1_Eg6iONvPOQ130_assertion wasGeneratedBy ECO_0000203 NP361046.RAhB1XETVT8GvU1_6S_7OCE7n4BTDGFHZ1_Eg6iONvPOQ130_provenance.
- befree-20140225 importedOn "2014-02-25" NP361046.RAhB1XETVT8GvU1_6S_7OCE7n4BTDGFHZ1_Eg6iONvPOQ130_provenance.